Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
123 hedge funds and large institutions have $807M invested in Intersect ENT, Inc in 2021 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 29 closing their positions.
63% more capital invested
Capital invested by funds: $495M → $807M (+$312M)
59% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 29
15% more funds holding
Funds holding: 107 → 123 (+16)
13% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 30
86% less call options, than puts
Call options by funds: $262K | Put options by funds: $1.91M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$63.2M |
| 2 |
VI
Versor Investments
New York
|
+$55.8M |
| 3 |
Millennium Management
New York
|
+$35.7M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$34.4M |
| 5 |
Morgan Stanley
New York
|
+$13.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$74.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$59.5M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$17.4M |
| 4 |
Jennison Associates
New York
|
-$15.5M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$12M |
XENT Hedge Fund Activity: Q3 2021 in Review
123 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2021, worth a combined $807M — up 63% from $495M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new XENT positions and 29 closed out — a net gain of 17 holders — while 34 added to existing stakes and 30 trimmed.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $63.2M. The largest seller was Artisan Partners, cutting an estimated $74.7M.
- 123 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2021, up from 107 in Q2 2021.
- Funds reported $807M of Intersect ENT, Inc stock for Q3 2021, up 63% quarter-over-quarter.
- 46 funds opened new Intersect ENT, Inc positions in Q3 2021 and 29 closed out, a net change of +17 holders.
- The largest Intersect ENT, Inc buyer in Q3 2021 was Magnetar Financial, an estimated $63.2M added.
- The largest Intersect ENT, Inc seller in Q3 2021 was Artisan Partners, an estimated $74.7M sold.
Based on aggregated 13F filings for Q3 2021.